Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
General Healthcare
Filter
Journals
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
RCTs with Improved Evidence Certainty Needed for AP-DGBIs
April 2025
Discover which treatments for abdominal pain-related disorders of gut-brain interaction are effective in this meta-analysis.
Read more
4 Mar 2015
Saving Precious Time: Siemens’ New Ultrasound System for Faster Imaging
At this year’s European Congress of Radiology (ECR) in Vienna, Austria, Siemens Healthcare introduces its new hand-carried Acuson P500 ultrasound system…
27 Feb 2015
Gilead Announces SVR12 Rates from Phase 3 Study Evaluating Harvoni® for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV
Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from a Phase 3 study, ION-4, evaluating the once-daily…
27 Feb 2015
Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF)
Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced detailed 48week results from two Phase 3 studies (Studies 104 and 111)…
16 Feb 2015
Hospira Launches First Biosimilar Monoclonal Antibody (mAb) InflectraTM (Infliximab) in Major European Markets
LAKE FOREST, Ill., February 16, 2015 — Hospira, Inc. (NYSE: HSP), a world leader in the development of biosimilar therapies, today announced the launch…
3 Feb 2015
New Stats Reveal Almost Half of the UK Are Unaware of Crucial Link between Diet and Cancer Development
Surprising new statistics reveal that 41% of the British population are oblivious to the role that diet plays in the development of cancer…
26 Jan 2015
The Outdoors Meets Human Anatomy on New EMJ Covers
The novel creative graphics for our eJournal front pages have stemmed from a desire to make our covers more imaginative and interesting.
23 Jan 2015
Basilea Announces That FDA’s Anti-Infective Drugs Advisory Committee Recommends Approval of Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis
Basel, Switzerland, January 22, 2015 – Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced that the U.S. Food and Drug Administration’s (FDA)…
19 Jan 2015
Stem Cells: The Cellular Origins of Fibrosis
POTENTIAL culprits that give rise to chronic tissue scarring, which can lead to the development of fibrosis, have been identified as a rare population of…
Loading posts...
« Previous
1
…
30
31
32
33
34
35
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View